Healthcare -
Biotechnology - NASDAQ - US
$ 0.6658
-6.33 %
$ 195 M
Market Cap
-0.84
P/E
LYEL - COST OF REVENUE
Cost of Revenue LYEL - Lyell Immunopharma, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR